Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cellular Biomedicine (CBMG)

Cellular Biomedicine (CBMG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,691
  • Shares Outstanding, K 19,478
  • Annual Sales, $ 340 K
  • Annual Income, $ -49,980 K
  • 60-Month Beta 1.17
  • Price/Sales 1,184.26
  • Price/Cash Flow N/A
  • Price/Book 22.15
Trade CBMG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.82
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/26/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility N/A
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.60 +12.22%
on 01/28/21
19.75 -0.03%
on 02/18/21
+1.59 (+8.76%)
since 01/19/21
3-Month
17.60 +12.22%
on 01/28/21
19.75 -0.03%
on 02/18/21
+1.40 (+7.63%)
since 11/19/20
52-Week
11.48 +72.04%
on 03/16/20
19.75 -0.03%
on 02/18/21
+2.88 (+17.07%)
since 02/19/20

Most Recent Stories

More News
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates UROV, WTRE, CBMG, NAV; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

UROV : 16.24 (+0.06%)
WTRE : 19.67 (+0.92%)
CBMG : 19.75 (unch)
NAV : 44.50 (+0.16%)
ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV

NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

CBMG : 19.75 (unch)
CGIX : 4.61 (-2.33%)
UROV : 16.24 (+0.06%)
MERGER INVESTIGATION: Halper Sadeh LLP Investigates CBMG, ALSK, UROV, NAV; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CBMG : 19.75 (unch)
ALSK : 3.40 (+0.29%)
UROV : 16.24 (+0.06%)
NAV : 44.50 (+0.16%)
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties...

CBMG : 19.75 (unch)
CBLI : 3.17 (-7.31%)
WORK : 45.20 (+0.09%)
UROV : 16.24 (+0.06%)
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages HMSY, HCAP, CBMG, and AKER Shareholders to Contact the Firm

NEW YORK, NY / ACCESSWIRE / January 2, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: HMS Holdings Corp. (NASDAQ:HMSY) concerning potential...

HMSY : 36.98 (+0.01%)
HCAP : 9.66 (+1.68%)
CBMG : 19.75 (unch)
AKER : 4.94 (-9.52%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – HCAP, PRGX, PS, CBMG

NEW YORK, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

HCAP : 9.66 (+1.68%)
PRGX : 7.71 (+0.13%)
PS : 22.45 (+0.13%)
CBMG : 19.75 (unch)
Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Contact Law Firm

NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

CBMG : 19.75 (unch)
CLCT : 91.92 (+0.04%)
ARA : 11.52 (+0.17%)
TNAV : 4.79 (unch)
Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout

WILMINGTON, Del., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG ) regarding possible breaches...

CBMG : 19.75 (unch)
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm – CBMG, MVC, STND, EIDX

NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CBMG : 19.75 (unch)
MVC : 9.12 (+2.59%)
STND : 33.00 (+0.06%)
EIDX : 122.21 (-4.85%)
ALERT: Halper Sadeh LLP Encourages PNM, NAV, HDS, and CBMG Shareholders to Contact the Firm

NEW YORK, NY / ACCESSWIRE / December 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: PNM Resources, Inc. (NYSE:PNM) concerning potential...

PNM : 46.87 (+0.15%)
NAV : 44.50 (+0.16%)
HDS : 55.99 (+0.21%)
CBMG : 19.75 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments...

See More

Key Turning Points

3rd Resistance Point 19.78
2nd Resistance Point 19.76
1st Resistance Point 19.76
Last Price 19.75
1st Support Level 19.74
2nd Support Level 19.72
3rd Support Level 19.72

See More

52-Week High 19.75
Last Price 19.75
Fibonacci 61.8% 16.59
Fibonacci 50% 15.62
Fibonacci 38.2% 14.64
52-Week Low 11.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar